EUVIMEDEUVIMED entdecken
Crossref

Reprogramming viral entry for precision therapeutics

Lali K Medina Kauwe

Open Access Government · 16.04.2026 · 50 (1) · 132-137

DOI: 10.56367/oag-050-12372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Access Government, erschienen am 16.04.2026. Verfasst von Lali K Medina Kauwe.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reprogramming viral entry for precision therapeutics Here, Cedars-Sinai Medical Center synthesize foundational adenovirus biology with key advances to present a unified model of penton base structure, function, and translational reprogramming. Efficient intracellular delivery – specifically escape from the endosomal compartment into the cytosol – remains one of the most formidable challenges in nucleic acid and macromolecular therapeutics.1 Viruses solve this problem through evolutionarily refined mechanisms that integrate receptor targeting, intracellular trafficking, and membrane disruption.2 Among these viral solutions, the adenovirus penton base stands out as a structurally discrete yet biologically powerful capsid protein that orchestrates internalization and endosomal escape.

Zitieren

APA

Kauwe, L. K. M. (2026). Reprogramming viral entry for precision therapeutics. Open Access Government, 50(1), 132-137. https://doi.org/10.56367/oag-050-12372

Vancouver

Kauwe LKM. Reprogramming viral entry for precision therapeutics. Open Access Government. 2026;50(1):132-137. doi:10.56367/oag-050-12372

BibTeX
@article{Kauwe2026,
  author = {Kauwe, Lali K Medina},
  title = {Reprogramming viral entry for precision therapeutics},
  journal = {Open Access Government},
  year = {2026},
  volume = {50},
  number = {1},
  pages = {132--137},
  doi = {10.56367/oag-050-12372}
}
Kostenlos starten →